bioAffinity Technologies Q2 EPS $(0.20) Down From $(0.03) YoY, Sales $19.74K Up From $1.31K YoY
Portfolio Pulse from Benzinga Newsdesk
bioAffinity Technologies reported Q2 losses of $(0.20) per share, a 566.67% decrease YoY. However, the company's sales increased by 1.41K% to $19.74K YoY.
August 14, 2023 | 9:41 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
bioAffinity Technologies reported a significant increase in losses per share for Q2, but also a substantial increase in sales.
The company's losses per share have significantly increased, which could negatively impact the stock price. However, the substantial increase in sales could offset this negative impact and potentially drive the stock price up. Therefore, the short-term impact on the stock price is uncertain.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100